|
1
|
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.
|
Blood
|
2011
|
4.45
|
|
2
|
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.
|
Blood
|
2009
|
2.12
|
|
3
|
Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia.
|
Blood
|
2012
|
1.81
|
|
4
|
Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.
|
Biol Blood Marrow Transplant
|
2008
|
1.41
|
|
5
|
National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants.
|
Biol Blood Marrow Transplant
|
2003
|
1.34
|
|
6
|
Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation.
|
Cancer
|
2009
|
1.06
|
|
7
|
Analysis of hematopoietic cell transplants using plasma-depleted cord blood products that are not red blood cell reduced.
|
Biol Blood Marrow Transplant
|
2007
|
0.96
|
|
8
|
Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myeloma.
|
Clin Cancer Res
|
2010
|
0.89
|
|
9
|
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.
|
Biol Blood Marrow Transplant
|
2011
|
0.85
|
|
10
|
Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long-term follow-up study.
|
Br J Haematol
|
2012
|
0.83
|
|
11
|
Persistence of CD30 expression in Hodgkin lymphoma following brentuximab vedotin (SGN-35) treatment failure.
|
Leuk Lymphoma
|
2012
|
0.83
|
|
12
|
Outcome of relapsed non-Hodgkin's lymphoma patients after allogeneic and autologous transplantation.
|
Cancer Invest
|
2002
|
0.79
|
|
13
|
Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia.
|
Br J Haematol
|
2014
|
0.79
|
|
14
|
Analysis of 120 pediatric patients with nonmalignant disorders transplanted using unrelated plasma-depleted or -reduced cord blood.
|
Transfusion
|
2011
|
0.76
|
|
15
|
Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphoma.
|
Leuk Lymphoma
|
2004
|
0.75
|
|
16
|
Association of hyperglycemia with prolonged hospital stay but no effect on engraftment after autologous hematopoietic stem cell transplantation.
|
Endocr Pract
|
2012
|
0.75
|